Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

Market Cap	5.50B
Revenue (ttm)	419.02M
Net Income (ttm)	-170.15M
Shares Out	159.27M
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,365,700
Average Volume	13,927,275
Open	35.52
Previous Close	34.54
Day's Range	33.23 - 36.58
52-Week Range	14.16 - 46.24
Beta	0.96
RSI	51.51
Earnings Date	Aug 28, 2025

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers medicines for anti-HBV, liver diseases, digestive, respiratory, cardiovascular, men’s health, and other fields. The company primarily produces crude drug and solid preparation in the forms of tablet, capsule, granule, medicinal tea, etc. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 760
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300436

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.